Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Harrison

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
Therapeutic Advances in Neurological Disorders|January 15, 2026
The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapyArian Lasocki, Simon J Harrison, Michael Dickinson, et al.
Leukemia & Lymphoma|December 5, 2008
Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapySimon J Harrison, Ian M Franklin, John D M Campbell
Haematologica|October 19, 2023
Multiplex immunohistochemistry elucidates increased distance between cytotoxic T cells and plasma cells in relapsed myeloma, and identifies Lag-3 as the most common checkpoint receptor on cytotoxic T cells of myeloma patientsSlavisa Ninkovic, Louise E Purton, Simon J Harrison, et al.
The Journal of Hand Surgery, European Volume|December 16, 2022
The effect of diabetes mellitus on the outcome of surgery for cubital tunnel syndromePaul H C Stirling, Simon J Harrison, Jane E McEachan
Haematologica|September 6, 2015
Comment on "Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma"Simon J Harrison, Hang Quach, Andrew Spencer, et al.
Journal of Blood Medicine|August 19, 2016
Update and new approaches in the treatment of Castleman diseaseKah-Lok Chan, Stephen Lade, H Miles Prince, et al.
Leukemia & Lymphoma|January 5, 2016
Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapiesBenjamin W Teh, Simon J Harrison, Leon J Worth, et al.
European Journal of Haematology|October 8, 2016
Epidemiology of bloodstream infections in patients with myeloma receiving current era therapyBenjamin W Teh, Simon J Harrison, Monica A Slavin, et al.
Expert Review of Anticancer Therapy|December 22, 2006
Immunotherapy of multiple myeloma: the start of a long and tortuous journeySimon J Harrison, Gordon Cook, Robert J B Nibbs, et al.
Leukemia & Lymphoma|August 23, 2013
Myeloma and pregnancy: strange bedfellows?Amit S Khot, H Miles Prince, Simon J Harrison, et al.
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
Therapeutic Advances in Neurological Disorders|January 15, 2026
The role of neuroimaging in neurotoxicity after chimeric antigen receptor T-cell therapyArian Lasocki, Simon J Harrison, Michael Dickinson, et al.
Leukemia & Lymphoma|December 5, 2008
Enumeration of blood dendritic cells in patients with multiple myeloma at presentation and through therapySimon J Harrison, Ian M Franklin, John D M Campbell
Haematologica|October 19, 2023
Multiplex immunohistochemistry elucidates increased distance between cytotoxic T cells and plasma cells in relapsed myeloma, and identifies Lag-3 as the most common checkpoint receptor on cytotoxic T cells of myeloma patientsSlavisa Ninkovic, Louise E Purton, Simon J Harrison, et al.
The Journal of Hand Surgery, European Volume|December 16, 2022
The effect of diabetes mellitus on the outcome of surgery for cubital tunnel syndromePaul H C Stirling, Simon J Harrison, Jane E McEachan
Haematologica|September 6, 2015
Comment on "Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma"Simon J Harrison, Hang Quach, Andrew Spencer, et al.
Journal of Blood Medicine|August 19, 2016
Update and new approaches in the treatment of Castleman diseaseKah-Lok Chan, Stephen Lade, H Miles Prince, et al.
Leukemia & Lymphoma|January 5, 2016
Antiviral prophylaxis for varicella zoster virus infections in patients with myeloma in the era of novel therapiesBenjamin W Teh, Simon J Harrison, Leon J Worth, et al.
European Journal of Haematology|October 8, 2016
Epidemiology of bloodstream infections in patients with myeloma receiving current era therapyBenjamin W Teh, Simon J Harrison, Monica A Slavin, et al.
Expert Review of Anticancer Therapy|December 22, 2006
Immunotherapy of multiple myeloma: the start of a long and tortuous journeySimon J Harrison, Gordon Cook, Robert J B Nibbs, et al.
Leukemia & Lymphoma|August 23, 2013
Myeloma and pregnancy: strange bedfellows?Amit S Khot, H Miles Prince, Simon J Harrison, et al.
Pageof 16